Literature DB >> 8294465

Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts.

Z Szallasi1, C B Smith, G R Pettit, P M Blumberg.   

Abstract

Bryostatin 1 and phorbol 12-myristate 13-acetate (PMA) are both potent activators of protein kinase C (PKC), although in many systems bryostatin 1 induces only a subset of the responses to PMA and blocks those which it does not induce. We report here that in NIH 3T3 fibroblasts PMA showed similar potencies for translocating PKC isozymes alpha, delta, and epsilon to the Triton X-100-soluble and -insoluble fractions and for the down-regulation of the three isozymes. Bryostatin 1 was slightly was more potent than PMA for down-regulating it. Bryostatin 1 was markedly more potent than PMA for translocating PKC delta but showed a biphasic dose-response curve for down-regulating this isozyme. 1-10 nM bryostatin 1 down-regulated PKC delta to a similar extent as PMA; lower (10-100 pM) or, unexpectedly, higher (100 nM to 1 microM) doses of bryostatin 1 caused either no or reduced down-regulation. Moreover, these high (100 nM to 1 microM) doses of bryostatin 1 inhibited the down-regulation of PKC delta by 1 microM PMA when coapplied. Bryostatin 1 caused translocation of PKC epsilon with slightly higher potency than PKC delta, but there was no protection of this isozyme at any of the doses examined. Bryostatin 1 induced a long-term increase in c-Jun level. The dose-response curve for bryostatin 1 was biphasic, with maximal induction at 1-10 nM bryostatin 1, coincident with the maximal down-regulation of PKC delta. We conclude that bryostatin 1 showed substantially different regulation for PKC alpha, PKC delta, and PKC epsilon, whereas PMA distinguished only weakly between these isozymes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Enantioselective synthesis of (-)-exiguolide by iterative stereoselective dioxinone-directed Prins cyclizations.

Authors:  Erika A Crane; Thomas P Zabawa; Rebecca L Farmer; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-19       Impact factor: 15.336

2.  Molecular mechanisms of regulation of fast-inactivating voltage-dependent transient outward K+ current in mouse heart by cell volume changes.

Authors:  Guan-Lei Wang; Ge-Xin Wang; Shintaro Yamamoto; Linda Ye; Heather Baxter; Joseph R Hume; Dayue Duan
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

Review 3.  The life and death of protein kinase C.

Authors:  Christine M Gould; Alexandra C Newton
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

4.  Characterization of the differential roles of the twin C1a and C1b domains of protein kinase C-delta.

Authors:  Yongmei Pu; Susan H Garfield; Noemi Kedei; Peter M Blumberg
Journal:  J Biol Chem       Date:  2008-11-10       Impact factor: 5.157

5.  Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity.

Authors:  Paul A Wender; Jeremy L Baryza; Stacey E Brenner; Brian A DeChristopher; Brian A Loy; Adam J Schrier; Vishal A Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

Review 6.  Role of protein kinase activity in apoptosis.

Authors:  M F Lavin; D Watters; Q Song
Journal:  Experientia       Date:  1996-10-31

7.  Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Authors:  Julia A Callender; Yimin Yang; Gema Lordén; Natalie L Stephenson; Alexander C Jones; John Brognard; Alexandra C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

8.  Protein kinase C epsilon is localized to the Golgi via its zinc-finger domain and modulates Golgi function.

Authors:  C Lehel; Z Olah; G Jakab; W B Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengths.

Authors:  Maria J Comin; Gabriella Czifra; Noemi Kedei; Andrea Telek; Nancy E Lewin; Sofiya Kolusheva; Julia F Velasquez; Ryan Kobylarz; Raz Jelinek; Peter M Blumberg; Victor E Marquez
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.